| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 653.13M | 637.06M | 594.08M | 681.09M | 520.17M | 181.08M |
| Gross Profit | 102.83M | 121.69M | 105.84M | 112.87M | 86.80M | 37.97M |
| EBITDA | 42.42M | 41.53M | 44.30M | 52.90M | 29.49M | 17.47M |
| Net Income | 10.69M | 6.53M | 15.37M | 27.74M | 12.39M | 9.66M |
Balance Sheet | ||||||
| Total Assets | 444.18M | 452.06M | 451.04M | 382.61M | 368.27M | 158.37M |
| Cash, Cash Equivalents and Short-Term Investments | 19.99M | 23.11M | 15.58M | 21.64M | 25.03M | 8.59M |
| Total Debt | 105.37M | 98.90M | 90.58M | 45.62M | 36.87M | 24.04M |
| Total Liabilities | 254.22M | 263.33M | 259.16M | 207.24M | 213.79M | 72.94M |
| Stockholders Equity | 189.96M | 188.74M | 192.01M | 175.51M | 154.57M | 85.44M |
Cash Flow | ||||||
| Free Cash Flow | 15.11M | 28.37M | 15.81M | 23.41M | 12.32M | 4.53M |
| Operating Cash Flow | 19.53M | 32.73M | 22.31M | 33.64M | 19.12M | 10.20M |
| Investing Cash Flow | -1.89M | -1.40M | -50.97M | -25.13M | -52.92M | -5.88M |
| Financing Cash Flow | -18.70M | -34.06M | 26.81M | -24.56M | 50.25M | -22.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.65B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
73 Outperform | £8.35B | 38.47 | 14.17% | 1.13% | 11.82% | 42.93% | |
68 Neutral | £1.71B | 13.32 | 8.38% | 3.99% | 5.75% | 5.86% | |
67 Neutral | £168.80M | 5.60 | 5.64% | 6.70% | 8.83% | 27.20% | |
64 Neutral | £191.94M | 0.64 | 7.92% | 6.53% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | £98.10M | -1.82 | -47.73% | ― | -2.08% | -9.83% |